Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation

Five Star Equities Provides Stock Research on Biosante Pharmaceuticals and ZIOPHARM Oncology

Continue Reading

ECB and Bank of England Leaves Interest Rates Unchanged – Euro Zone Economy Expected to Start Stabilizing in Second Half of 2013

RDInvesting Provides Stock Research on Deutsche Bank and HSBC

Continue Reading

FDA Programs Designed to Speed Up Approval Process Helps Send Drug Approvals to a 15-Year High in 2012

Five Star Equities Provides Stock Research on Aegerion Pharmaceuticals and Alnylam

Continue Reading

FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Five Star Equities Provides Stock Research on Idenix Pharmaceuticals and Peregrine Pharmaceuticals

Continue Reading

Dow Jones Industrial Average Reach Record High – Dividend Payments From Dow 30 Not Far Behind

RDINvesting Provides Stock Research on AT&T and Microsoft

Continue Reading

17 out of 18 U.S. Big Banks Past Latest Round of Stress Tests

Five Star Equities Provides Stock Research on JPMorgan Chase & Co. and Morgan Stanley

Continue Reading

New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on Halozyme Therapeutics and Novavax

Continue Reading

ECB Leaves Interest Rate at Record Low 0.75% – Euro Zone Could See Growth Return in 2014

RDInvesting Provides Stock Research on Bank of Ireland and Royal Bank of Scotland Group

Continue Reading

Blue Chip Garnering Increased Attention as Dow Hits Record High

RDINvesting Provides Stock Research on 3M and United Technologies

Continue Reading

Dividends From the Dow 30 Reach Highest Level Since Before the Financial Crisis

RDINvesting Provides Stock Research on Du Pont and The Home Depot

Continue Reading